SUANNUTRA and Myota Partner to Deliver Precision Prebiotic Solutions Across US, UK, and EU
Myota's Metabolic Regulator offers precision-formulated, science-backed prebiotic fibers to support healthy metabolism
BARCELONA, Spain, May 13, 2025 /PRNewswire/ -- SUANNUTRA, a global leader in nutraceutical ingredients, has entered an exclusive distribution agreement with UK-based Myota to launch its clinically backed prebiotic fiber blends—including the flagship Metabolic Regulator—across the US, UK, and EU[1].
At the heart of this collaboration lies a powerful scientific synergy: Myota's patented blend of nine plant-based fibres promotes the direct production of beneficial short-fatty acids (SCFAs) through targeted fermentation by gut microbiota. SUANNUTRA's flagship ingredient, Metabolaid®, complements this effect by indirectly supporting SCFA generation via microbiome modulation. These SCFAs play a key role in the stimulation of GLP-1. In addition, Metabolaid® activates AMPK pathway and helping maintain healthy lipid metabolism and blood pressure levels. Together, these technologies deliver a synergistic, multi-pathway approach to metabolic health - enhancing prebiotic action at the gut level and supporting systemic metabolic balance.
Metabolic Regulator has been studied for supporting healthy blood sugar levels, maintaining cholesterol already within a normal range, and minimising postprandial glucose spikes with evidence drawn from MIT research and third-party clinical trials. Its low-FODMAP, clean-label formulation is suitable even for those with digestive sensitivities.
"This partnership enhances our portfolio with targeted microbiome-nourishing solutions, providing next-gen support for cardiometabolic wellness," said Anthony Weston, CEO of SUANNUTRA. "By combining Metabolaid®'s support of key metabolic pathways with Myota's microbiome-driven prebiotic approach, we're delivering a complementary dual-action approach to today's metabolic health needs."
Thomas Gurry, PhD, CEO of Myota, added: "We see immense value in pairing our fermentation-optimized prebiotics with SUANNUTRA's clinically vetted actives. Together, we are shifting the paradigm from generic gut health to precision-formulated, systemic wellness."
The full range, including blends for immune and digestive health, will debut at Vitafoods Europe 2025 (May 20–22, Booth #3K22). Custom blends and formulation support will also be available through SUANNUTRA.
About SUANNUTRA and Myota
About SUANNUTRA
SUANNUTRA is a Global leading nutraceutical ingredient player, offering a growing portfolio of scientifically backed, clinically proven branded & functional ingredient sourcing. SUANNUTRA boasts more than 22 clinical studies, and 6 awards won across a proprietary and scientifically endorsed, branded ingredients portfolio addressing the Weight Management, Beauty from Within and Women's Health segments, by leveraging innovative science and underpinned by a strong pipeline.
About Myota
Founded in 2019, Myota develops clean-label, low-FODMAP prebiotic blends grounded in nearly a decade of research at MIT. Focused on tailoring fiber blends to individual microbiome profiles, Myota ensures maximum fermentation efficiency and clinical efficacy—bridging gut and metabolic health.
1. Excludes Germany and Austria.
Photo: https://mma.prnewswire.com/media/2686008/SUANNUTRA_and_Myota_Partner.jpg
For more information, please contact:
SUANNUTRA
Website: suannutra.com
Email: info@suannutra.com
Myota
Website: myotahealth.com
Email: info@myotahealth.com
Press Contact
NutriPR
Liat Simha
Email: liat@nutripr.com
Tel.: +972-9-9742893
View original content to download multimedia:https://www.prnewswire.com/news-releases/suannutra-and-myota-partner-to-deliver-precision-prebiotic-solutions-across-us-uk-and-eu-302453708.html
SOURCE SUANNUTRA; Myota